Clinical Trials/ACTRN12620001173987

ACTRN12620001173987

Active, Not Recruiting

N/A

Optimising outcomes for frail hospitalised older adults – nurse led volunteer support and pain assessment interventions: A cluster randomised control trial

Edith Cowan University0 sites421 target enrollmentNovember 9, 2020

Overview

Phase: N/A
Intervention: Not specified
Conditions: Not specified
Sponsor: Edith Cowan University
Enrollment: 421
Status: Active, Not Recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

November 9, 2020

End Date

TBD

Last Updated

3 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Edith Cowan University

Eligibility Criteria

Inclusion Criteria

•Patients aged 65 years and over admitted to participating wards
•Anticipated length of hospital stay 48 hours or longer
•Score greater than or equal to 8 on the modified\-Reported Edmonton Frail Scale (mod\-REFS)

Exclusion Criteria

•Non\-medical patient
•Severe intellectual disability
•Patients who requires isolation due to infection control precautions

Outcomes

Primary Outcomes

Not specified

Similar Trials

Optimising acute delirium care in Tan Tock Seng Hospital

ISRCTN52323811Ministry of Health (Singapore)200

Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosis

ISRCTN35836727Record Provided by the NHSTCT Register - 2006 Update - Department of Health20

Minimising functional decline amongst older adults with a novel intervention against a traditional intervention.

ACTRN12610000909022Singhealth Foundation40

Active, Not Recruiting

Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.

EUCTR2016-002272-27-BESaarland University388

Active, Not Recruiting

Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]

EUCTR2016-002272-27-ATSaarland University388